Nutrition Unlocked - Staying Strong As We Age

Presented by Prof. Ralf Heine (Paediatric Gastroenterologist and Allergist), this session will cover how to recognise and diagnose CMA in infants, the nutritional risks of delayed diagnosis, how to distinguish CMA from lactose intolerance, and the role of tailored nutrition in supporting symptom resolution, growth, and healthy gut and immune development. Learning Outcomes: 1. Identify the key steps in recognising and conducting diagnostic evaluations for infants with suspected Cow’s Milk Allergy (CMA) 2. Describe the nutritional risks associated with delayed diagnosis of Cow’s Milk Allergy (CMA) in infants and differentiate symptoms of CMA from those of lactose intolerance. 3. Summarise the impact of Cow’s Milk Allergy (CMA) on the gut microbiome and immune system maturation, and evaluate evidence-based nutritional interventions that support growth, symptom resolution, and promote gut and immune health in affected infants IMPORTANT NOTICE: Breast milk is best for baby and provides ideal nutrition. Good maternal nutrition is important for preparation and maintenance of breastfeeding. Introducing partial bottle feeding could negatively affect breastfeeding and reversing a decision not to breastfeed is difficult. Professional advice should be followed on infant feeding. Infant formula should be prepared and used exactly as directed or it could pose a health hazard. The preparation requirements and cost of providing infant formula until 12 months of age should be considered before making a decision to formula feed. Mothers should be encouraged to continue breastfeeding even when their infants have cow’s milk protein allergy. If a decision to use an infant formula for special dietary use or special medical purpose product for infants is taken, it must be used under medical supervision.

In this education module, learn from expert metabolic health GP and dietitian Dr Terri-Lynne South on the nutritional risks, considerations and optimal dietary intake for patients on GLP-1 RA therapy for weight loss. ​ Learning Objectives:​ Identify the nutritional risks associated with GLP-1 RA therapy for weight loss​ Summarise the nutritional requirements to be considered for individuals on GLP-1 RA therapy ​ Outline how to optimise the nutrition of your patients who are prescribed GLP-1 RAs

This study demonstrates that the use of Sn-2 formula compared to standard infant formula may be associated with improved behaviors and stool characteristics in infants.

Neurological disability is often associated with feeding and gastrointestinal disorders leading to malnutrition and growth failure. These clinical guidelines by ESPGHAN provide necessary nutritional and clinical guidance including assessment and monitoring of nutritional status, definition of nutritional requirements, diagnosis and treatment of gastro-oesophageal reflux disease, and indications for and modalities of nutritional support.

The symposium review article

OverviewLeveraging the combined expertise of a General Practitioner, Paediatrician, Allergist and Dietitian, this session will walk through two real world case studies that illustrate the infant journey from first presentation to diagnosis and coordinated management.What this session will highlight:- Early recognition of CMA in busy primary care settings- Practical, evidence based pathways to reduce delay in diagnosis- How multidisciplinary collaboration supports effective symptom management- Approaches to establishing a care plan that promotes healthy growth and developmentSpeakersSusan Jones (Chair)Global Medical Affairs Lead for Paediatric Allergy Nestle Health Science, SwitzerlandDr Nicholas CoolingGP Allergist, Chair, RACGP Allergy SIG Allergy Tasmania & Senior Lecturer UTASDr David TranGeneral Paediatrician & Paediatric AllergySpecialist, Northern HealthDr Marnie RobinsonPaediatric Allergist & ImmunologistRoyal Children’s Hospital &Melbourne Allergy Centre & Children'sSpecialists (MACCS)Marianne TomlinPaediatric Allergy Dietitian Monash Children’s HospitalBREASTFEEDING IS BEST FOR BABIES.Information for healthcare professional use only.

This presentation by Lauren Atkins provides key nutrition-focused strategies for nurses supporting patients under 50 with colorectal cancer. It highlights early recognition of malnutrition and sarcopenia beyond BMI, the importance of protein and muscle preservation, timely initiation of supplements, and proactive referral and reinforcement to optimise treatment tolerance and long-term outcomes.

Older adults are one of the fastest-growing populations in the United States, representing more than 1 in every 6 Americans. Aging is associated with an increased risk for sarcopenia, obesity, and sarcopenic obesity, all of which may contribute to poorer quality of life. Among older adults, the prevalence of obesity is 36-43%, sarcopenia 10-27%, and sarcopenic obesity 10%.

GLP-1 therapies are transforming weight management, but supporting patients effectively means looking beyond the number on the scale.In this on-demand webinar, a multidisciplinary faculty explores nutritional adequacy, muscle health, and lifestyle considerations for patients on GLP-1 therapy, using real-world case-based scenarios and providing practical guidance for your next consultation.Speakers: Dr Angela Kwong (GP), Dr Terri-Lynne South (GP & APD), Dr Emily Lewis (APD & AEP)Panel Chair: Prof. Leonidas Karagounis (Professor of Research Translation & Enterprise, MMIHR/ACU)

This brochure provides a summary of Nestlé Health Sciences key nutritional supplements products.

The Hydration Status of Adult Patients with Oropharyngeal Dysphagia and the Effect of Thickened Fluid Therapy on Fluid Intake and Hydration: Results of Two Parallel Systematic and Scoping Reviews.Click here to view the PDF.